Trials / Completed
CompletedNCT04477733
Effect of Butorphanol on Colonoscopy for Patients With Postoperative Visceral Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- Beijing Tiantan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The total incidence of abdominal pain after colonoscopy is almost 50%. Butorphanol is a mixed opioid receptor agonist-antagonist, which has strong sedative and analgesic effects. This clinical study aims to explore the effectiveness and safety of butorphanol combined with propofol for colonoscopy to reduce postoperative visceral pain, and provide a basis for improving the quality of surgery and comfortable medical treatment for patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Butorphanol Injection | Inject 10 μg/kg of butorphanol, then propofol is injected until the patient's eyelash reflex disappears before performing colonoscopy |
| DRUG | Saline | Inject saline and propofol until the patient's eyelash reflex disappears before performing colonoscopy |
Timeline
- Start date
- 2020-08-14
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2020-07-20
- Last updated
- 2022-02-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04477733. Inclusion in this directory is not an endorsement.